Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe: A Follow-up Physician Survey First published 04/09/2019 Last updated 01/04/2024 EU PAS number:EUPAS30727 Study Finalised